C-reactive protein and D-dimer in cerebral vein thrombosis: Relation to clinical and imaging characteristics as well as outcomes in a French cohort study.

Fiche publication

Date publication

mars 2023

Journal

Research and practice in thrombosis and haemostasis

Auteurs

Membres identifiés du Cancéropôle Est :
Pr MOULIN Thierry

Tous les auteurs :
Billoir P, Siguret V, Fron EM, Drouet L, Crassard I, Marlu R, Barbieux-Guillot M, Morange PE, Robinet E, Metzger C, Wolff V, André-Kerneis E, Klapczynski F, Martin-Bastenaire B, Pico F, Menard F, Ellie E, Freyburger G, Rouanet F, Allano HA, Godenèche G, Mourey G, Moulin T, Berruyer M, Derex L, Trichet C, Runavot G, Le Querrec A, Viader F, Cluet-Dennetiere S, Husein TT, Donnard M, Macian-Montoro F, Ternisien C, Guillon B, Laplanche S, Zuber M, Peltier JY, Tassan P, Roussel B, Canaple S, Scavazza E, Gaillard N, Triquenot Bagan A, Le Cam Duchez V

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/37138790

Résumé

Cerebral venous sinus thrombosis (CVST) is a rare disease with highly variable clinical presentation and outcomes. Clinical studies suggest a role of inflammation and coagulation in CVST outcomes. The aim of this study was to investigate the association of inflammation and hypercoagulability biomarkers with CVST clinical manifestations and prognosis.